Company news
Orexo Ab (OMXSTO:ORX) news
Orexo Ab news releases on 6ix. Latest, Sep 1, 2026: Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
Press releases & updates
Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
August 31, 2026
Orexo appoints Raheleh Nassaji as SVP Business Development, strengthening its focus on new partnerships
June 9, 2026
Orexo announces positive outcome from an in-vivo study of OX390
May 19, 2026
Orexo : Earnings Call Q1 2026 (engelska)
April 28, 2026
Orexo : Earnings Call Q1 2026
April 28, 2026
Orexo : Q1 2026 Interim Report MASTER
April 28, 2026
Orexo : Q1 2026 Interim Report 2026
April 28, 2026
Orexo Q1 2026 Interim Report
April 28, 2026
Invitation to presentation of Orexo´s Q1 2026 Interim Report
April 21, 2026
Orexo publishes Annual Report for 2025
March 27, 2026
Orexo changes the organizational structure and management team to increase focus on development of new products
March 6, 2026
Orexo calls for early redemption of its outstanding senior secured social bonds 2024/2028
March 4, 2026
Orexo: Conversion of Class C shares into ordinary shares and conveyance of ordinary shares within the framework of long-term performance-based incentive programs
February 19, 2026
Orexo Interim Report Q4 2025, incl. Full Year Report
February 5, 2026
Dexcel Pharma USA Acquires US Rights to Zubsolv®
January 7, 2026
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
September 5, 2025
Seminar: IP That Matters - Behind Orexo's Milestone Patent Win at the US Court
August 29, 2025
Orexo to present clinical data for OX640 at the EAACI Congress
June 2, 2025